Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2009 1
2011 3
2012 2
2013 4
2014 3
2015 2
2016 3
2017 13
2018 9
2019 14
2020 18
2021 21
2022 22
2023 23
2024 36
2025 35
2026 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing.
Venetis K, Pepe F, Pescia C, Cursano G, Criscitiello C, Frascarelli C, Mane E, Russo G, Taurelli Salimbeni B, Troncone G, Guerini Rocco E, Curigliano G, Fusco N, Malapelle U. Venetis K, et al. Among authors: pepe f. Cancer Treat Rev. 2023 Dec;121:102642. doi: 10.1016/j.ctrv.2023.102642. Epub 2023 Oct 13. Cancer Treat Rev. 2023. PMID: 37864956 Review.
Osimertinib.
Malapelle U, Ricciuti B, Baglivo S, Pepe F, Pisapia P, Anastasi P, Tazza M, Sidoni A, Liberati AM, Bellezza G, Chiari R, Metro G. Malapelle U, et al. Among authors: pepe f. Recent Results Cancer Res. 2018;211:257-276. doi: 10.1007/978-3-319-91442-8_18. Recent Results Cancer Res. 2018. PMID: 30069773 Review.
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery.
Marchetti C, Ergasti R, Capomacchia FM, Giannarelli D, Mastrantoni L, Pepe F, Apostol AI, Sassu CM, Nero C, Piermattei A, Zannoni GF, Troncone G, Colomban O, Russo G, Carrot A, Malapelle U, You B, Lorusso D, Scambia G, Fagotti A. Marchetti C, et al. Among authors: pepe f. Gynecol Oncol. 2025 Apr;195:16-25. doi: 10.1016/j.ygyno.2025.02.016. Epub 2025 Mar 5. Gynecol Oncol. 2025. PMID: 40048982 Free article.
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy.
Venetis K, Cursano G, Scafetta R, Giachetti PPMB, Concardi A, De Camilli E, D'Ercole M, Mane E, Frascarelli C, Marra A, Gandini S, Pepe F, Scagnoli S, Rossi SM, Troiano R, Speziale E, De Angelis C, Troncone G, Malapelle U, Perrone G, Botticelli A, Viale G, Curigliano G, Guerini Rocco E, Criscitiello C, Fusco N. Venetis K, et al. Among authors: pepe f. Breast Cancer Res. 2025 May 14;27(1):79. doi: 10.1186/s13058-025-02020-x. Breast Cancer Res. 2025. PMID: 40369610 Free PMC article.
BRAF: A Two-Faced Janus.
Pisapia P, Pepe F, Iaccarino A, Sgariglia R, Nacchio M, Russo G, Gragnano G, Malapelle U, Troncone G. Pisapia P, et al. Among authors: pepe f. Cells. 2020 Nov 27;9(12):2549. doi: 10.3390/cells9122549. Cells. 2020. PMID: 33260892 Free PMC article. Review.
Correlation Hyperspectral Imaging.
Massaro G, Pepe FV, D'Angelo M. Massaro G, et al. Among authors: pepe fv. Phys Rev Lett. 2024 Nov 1;133(18):183802. doi: 10.1103/PhysRevLett.133.183802. Phys Rev Lett. 2024. PMID: 39547179
Next generation sequencing in cytology.
Pisapia P, Pepe F, Sgariglia R, Nacchio M, Russo G, Conticelli F, Girolami I, Eccher A, Bellevicine C, Vigliar E, Malapelle U, Troncone G. Pisapia P, et al. Among authors: pepe f. Cytopathology. 2021 Sep;32(5):588-595. doi: 10.1111/cyt.12974. Epub 2021 Apr 1. Cytopathology. 2021. PMID: 33792981 Free PMC article. Review.
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer.
Guerini-Rocco E, Venetis K, Cursano G, Mane E, Frascarelli C, Pepe F, Negrelli M, Olmeda E, Vacirca D, Ranghiero A, Trapani D, Criscitiello C, Curigliano G, Rolfo C, Malapelle U, Fusco N. Guerini-Rocco E, et al. Among authors: pepe f. Crit Rev Oncol Hematol. 2024 Sep;201:104427. doi: 10.1016/j.critrevonc.2024.104427. Epub 2024 Jun 23. Crit Rev Oncol Hematol. 2024. PMID: 38917944 Review.
Correlation Plenoptic Imaging.
D'Angelo M, Pepe FV, Garuccio A, Scarcelli G. D'Angelo M, et al. Among authors: pepe fv. Phys Rev Lett. 2016 Jun 3;116(22):223602. doi: 10.1103/PhysRevLett.116.223602. Epub 2016 Jun 3. Phys Rev Lett. 2016. PMID: 27314718
Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C-mutated advanced non-small cell lung cancer.
Passiglia F, Pepe F, Russo G, Garbo E, Listì A, Benso F, Scimone C, Palumbo L, Pluchino M, Minari R, Bordi P, Cani M, Ungaro A, Ambrogio C, Taulli R, Capelletto E, Balbi M, Righi L, Tiseo M, Giannarelli D, Troncone G, Novello S, Malapelle U. Passiglia F, et al. Among authors: pepe f. Cancer. 2025 Jun 1;131(11):e35917. doi: 10.1002/cncr.35917. Cancer. 2025. PMID: 40445863 Free PMC article.
187 results